Characteristic | Lymph node positive (n = 58) | Lymph node negative (n = 78) | P-value |
---|---|---|---|
Median age at diagnosis (range), yrs | 66.7 (50.9 – 76.8) | 67.4 (48.3 – 79.1) | 0.03 |
Mode of detection, n (%) | 0.17 | ||
Symptomatic | 25 (43) | 25 (32) | |
Screening | 33 (57) | 53 (68) | |
Median PSA (range), ng/mL | 24.4 (1.8 – 109.0) | 26.0 (2.9 – 109.0) | 0.26 |
Gleason sum, n (%) | 0.21 | ||
3 + 3 | 3 (5) | 1 (1) | |
3 + 4 | 10 (17) | 8 (10) | |
4 + 3 | 13 (22) | 22 (28) | |
4 + 4 | 23 (40) | 29 (37) | |
4 + 5 | 5 (9) | 16 (21) | |
5 + 4 | 3 (5) | 2 (3) | |
5 + 5 | 1 (2) | 0 (0) | |
Clinical stage, n (%) | 0.58 | ||
T1b | 1 (2) | 0 (0) | |
T1c | 1 (2) | 6 (8) | |
T2a | 3 (3) | 1 (1) | |
T2b | 3 (5) | 4 (5) | |
T2c | 3 (5) | 3 (4) | |
T3a | 23 (40) | 32 (41) | |
T3b | 23 (40) | 30 (38) | |
T4 | 1 (2) | 2 (3) | |
Median duration of ADT (range), months | 40.3 (11.9 – 54.4) | 28.7 (9.0 – 60.2) | <0.001 |